ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,702.08
-0.30%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Navamedic Asa (0FDB)

  7. Navamedic Asa (0FDB) Noticias

0FDB

Navamedic Asa (0FDB)

Navamedic Asa
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:0FDB
FechaHoraFuenteTítuloSímboloCompañía
21/12/202310:29PR Newswire (US)Navamedic ASA: Renewed contract signed with Vitaflo International LimitedLSE:0FDBNavamedic Asa
13/12/202312:18PR Newswire (US)Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in EuropeLSE:0FDBNavamedic Asa
01/11/202302:14PR Newswire (US)Navamedic ASA: Record high quarter with above 50 percent growthLSE:0FDBNavamedic Asa
27/10/202304:52PR Newswire (US)Navamedic ASA: Invitation to 2023 3rd quarter presentationLSE:0FDBNavamedic Asa
30/08/202306:20PR Newswire (US)Navamedic ASA - Registration of share capital increaseLSE:0FDBNavamedic Asa
18/08/202305:50PR Newswire (US)Navamedic ASA - Mandatory notification of trade by primary insiderLSE:0FDBNavamedic Asa
18/08/202305:27PR Newswire (US)NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee optionsLSE:0FDBNavamedic Asa
11/08/202301:41PR Newswire (US)Navamedic ASA: Significant growth across the businessLSE:0FDBNavamedic Asa
07/08/202305:40PR Newswire (US)Navamedic ASA: Invitation to 2023 2nd quarter presentationLSE:0FDBNavamedic Asa
01/06/202304:43PR Newswire (US)Navamedic ASA: Minutes of Annual General MeetingLSE:0FDBNavamedic Asa
31/05/202307:42PR Newswire (US)Updated recommendation by the nomination committee of Navamedic ASALSE:0FDBNavamedic Asa
26/05/202301:23PR Newswire (US)Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offerLSE:0FDBNavamedic Asa
11/05/202305:15PR Newswire (US)Navamedic ASA: Notice of Annual General MeetingLSE:0FDBNavamedic Asa
11/05/202301:57PR Newswire (US)Navamedic ASA Q1 2023: Another strong quarterLSE:0FDBNavamedic Asa
10/05/202302:15PR Newswire (US)Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose AktiebolagLSE:0FDBNavamedic Asa
08/05/202304:25PR Newswire (US)Navamedic ASA: Invitation to 2023 1st quarter presentationLSE:0FDBNavamedic Asa
28/04/202306:57PR Newswire (US)Navamedic ASA: Annual Report for 2022LSE:0FDBNavamedic Asa
23/04/202322:34PR Newswire (US)Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose ABLSE:0FDBNavamedic Asa
29/03/202301:13PR Newswire (US)Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 millionLSE:0FDBNavamedic Asa
16/02/202302:00PR Newswire (US)Navamedic ASA: Q4 2022 financial resultsLSE:0FDBNavamedic Asa
13/02/202302:19PR Newswire (US)Navamedic ASA: Invitation to 2022 4th quarter presentationLSE:0FDBNavamedic Asa
23/11/202204:30PR Newswire (US)Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic regionLSE:0FDBNavamedic Asa
01/11/202202:43PR Newswire (US)Navamedic ASA: Q3 2022 financial resultsLSE:0FDBNavamedic Asa
25/10/202209:01PR Newswire (US)Navamedic ASA: Invitation to 2022 third quarter presentationLSE:0FDBNavamedic Asa
20/10/202202:24PR Newswire (US)Navamedic ASA launches ForlaxGO® - an innovative on-the-go product for the treatment of constipationLSE:0FDBNavamedic Asa
12/08/202201:48PR Newswire (US)Navamedic ASA: Q2 and first half 2022 financial resultsLSE:0FDBNavamedic Asa
09/08/202207:40PR Newswire (US)Navamedic ASA: Invitation to 2022 second quarter presentationLSE:0FDBNavamedic Asa
04/08/202207:27PR Newswire (US)Navamedic ASA - Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®LSE:0FDBNavamedic Asa
04/07/202213:13PR Newswire (US)Navamedic ASA: Trading UpdateLSE:0FDBNavamedic Asa
01/06/202209:50PR Newswire (US)Navamedic ASA completes acquisition of Impolin AB and issues consideration sharesLSE:0FDBNavamedic Asa
 Showing the most relevant articles for your search:LSE:0FDB

Su Consulta Reciente

NYSE
BAC
Bank of America
NASDAQ
AAPL
Apple
USOTC
BASFY
BASF (QX)
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
NYSE
JPM
JP Morgan Chase
FX
EURMXN
Euro vs MXN
USOTC
ADDYY
Adidas (QX)
CCOM
OILBRENT
Brent Oil
NYSE
DIS
Walt Disney
USOTC
DTEGY
Deutsche Telekom (QX)
PM
XAUUSD
Gold vs US Dollar
NASDAQ
GOOGL
Alphabet
NASDAQ
TSLA
Tesla
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados